Human disease
head and neck squamous cell carcinoma
Mondo defines it as: “A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 1302 | Avian sarcoma and leukosis virus, subgroup B, susceptibility/resistance to | OMIA's OMIM numbers | 1 | Human disease |
34.0
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
Open Targets links none of these groups' human genes to this disease.
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Cosibelimab | None of these genes | Approved |
| Gefitinib | None of these genes | Approved |
| Nivolumab | None of these genes | Approved |
| Pembrolizumab | None of these genes | Approved |
| Afatinib | None of these genes | Phase 3 |
| Amivantamab | None of these genes | Phase 3 |
| Avelumab | None of these genes | Phase 3 |
| Becotatug Vedotin | None of these genes | Phase 3 |
| Bemcentinib | None of these genes | Phase 3 |
| Benmelstobart | None of these genes | Phase 3 |
| Bevacizumab | None of these genes | Phase 3 |
| Buparlisib | None of these genes | Phase 3 |
| Camrelizumab | None of these genes | Phase 3 |
| Capecitabine | None of these genes | Phase 3 |
| Carboplatin | None of these genes | Phase 3 |
| Cetuximab | None of these genes | Phase 3 |
| Cetuximab Sarotalocan | None of these genes | Phase 3 |
| Cisplatin | None of these genes | Phase 3 |
| Docetaxel Anhydrous | None of these genes | Phase 3 |
| Dostarlimab | None of these genes | Phase 3 |
| Durvalumab | None of these genes | Phase 3 |
| Dusquetide | None of these genes | Phase 3 |
| Endostatin | None of these genes | Phase 3 |
| Epacadostat | None of these genes | Phase 3 |
| Epinephrine | None of these genes | Phase 3 |
| Epoetin Alfa | None of these genes | Phase 3 |
| Erlotinib | None of these genes | Phase 3 |
| Feladilimab | None of these genes | Phase 3 |
| Ficlatuzumab | None of these genes | Phase 3 |
| Filgrastim | None of these genes | Phase 3 |
| Finotonlimab | None of these genes | Phase 3 |
| Fluorouracil | None of these genes | Phase 3 |
| Gimeracil | None of these genes | Phase 3 |
| Ipilimumab | None of these genes | Phase 3 |
| Ivonescimab | None of these genes | Phase 3 |
| Lapatinib | None of these genes | Phase 3 |
| Lenvatinib | None of these genes | Phase 3 |
| Linrodostat | None of these genes | Phase 3 |
| Megestrol Acetate | None of these genes | Phase 3 |
| Methotrexate | None of these genes | Phase 3 |
| Monalizumab | None of these genes | Phase 3 |
| Nedaplatin | None of these genes | Phase 3 |
| Nimorazole | None of these genes | Phase 3 |
| Nimotuzumab | None of these genes | Phase 3 |
| Oteracil | None of these genes | Phase 3 |
| Paclitaxel | None of these genes | Phase 3 |
| Palbociclib | None of these genes | Phase 3 |
| Panitumumab | None of these genes | Phase 3 |
| Pelareorep | None of these genes | Phase 3 |
| Petosemtamab | None of these genes | Phase 3 |
| Pexipepimut-S | None of these genes | Phase 3 |
| Talimogene Laherparepvec | None of these genes | Phase 3 |
| Tegafur | None of these genes | Phase 3 |
| Tislelizumab | None of these genes | Phase 3 |
| Toripalimab | None of these genes | Phase 3 |
| Tremelimumab | None of these genes | Phase 3 |
| Uracil | None of these genes | Phase 3 |
| Vinflunine | None of these genes | Phase 3 |
| Volrustomig | None of these genes | Phase 3 |
| Xevinapant | None of these genes | Phase 3 |
| Zalutumumab | None of these genes | Phase 3 |
| Atezolizumab | None of these genes | Phase 2/3 |
| Bempegaldesleukin | None of these genes | Phase 2/3 |
| Enoblituzumab | None of these genes | Phase 2/3 |
| Ficerafusp Alfa | None of these genes | Phase 2/3 |
| Gemcitabine | None of these genes | Phase 2/3 |
| H11 Scfv | None of these genes | Phase 2/3 |
| Oportuzumab Monatox | None of these genes | Phase 2/3 |
| Ponatinib | None of these genes | Phase 2/3 |
| Retifanlimab | None of these genes | Phase 2/3 |
| Tebotelimab | None of these genes | Phase 2/3 |
| Zanzalintinib | None of these genes | Phase 2/3 |
| Abemaciclib | None of these genes | Phase 2 |
| Acalabrutinib | None of these genes | Phase 2 |
| Adakitug | None of these genes | Phase 2 |
| Adavosertib | None of these genes | Phase 2 |
| Adebrelimab | None of these genes | Phase 2 |
| Adu-S100 | None of these genes | Phase 2 |
| Aldesleukin | None of these genes | Phase 2 |
| Alpelisib | None of these genes | Phase 2 |
| Alvocidib | None of these genes | Phase 2 |
| Amg-319 | None of these genes | Phase 2 |
| Axitinib | None of these genes | Phase 2 |
| Azacitidine | None of these genes | Phase 2 |
| Bavituximab | None of these genes | Phase 2 |
| Becotatug | None of these genes | Phase 2 |
| Belapectin | None of these genes | Phase 2 |
| Belrestotug | None of these genes | Phase 2 |
| Bimiralisib | None of these genes | Phase 2 |
| Bintrafusp Alfa | None of these genes | Phase 2 |
| Bleomycin | None of these genes | Phase 2 |
| Bortezomib | None of these genes | Phase 2 |
| Bryostatin 1 | None of these genes | Phase 2 |
| Cabazitaxel | None of these genes | Phase 2 |
| Cabozantinib | None of these genes | Phase 2 |
| Cadonilimab | None of these genes | Phase 2 |
| Catequentinib | None of these genes | Phase 2 |
| Cdx-3379 | None of these genes | Phase 2 |
| Cediranib | None of these genes | Phase 2 |
| Celecoxib | None of these genes | Phase 2 |
| Cemiplimab | None of these genes | Phase 2 |
| Charcoal, Activated | None of these genes | Phase 2 |
| Cixutumumab | None of these genes | Phase 2 |
| Cobimetinib | None of these genes | Phase 2 |
| Contusugene Ladenovec | None of these genes | Phase 2 |
| Cyclophosphamide Anhydrous | None of these genes | Phase 2 |
| Dacomitinib Anhydrous | None of these genes | Phase 2 |
| Dalantercept | None of these genes | Phase 2 |
| Dalpiciclib | None of these genes | Phase 2 |
| Danvatirsen | None of these genes | Phase 2 |
| Dasatinib Anhydrous | None of these genes | Phase 2 |
| Demplatin Pegraglumer | None of these genes | Phase 2 |
| Dichloroacetic Acid | None of these genes | Phase 2 |
| Domvanalimab | None of these genes | Phase 2 |
| Doxycycline Anhydrous | None of these genes | Phase 2 |
| Duligotuzumab | None of these genes | Phase 2 |
| Duvelisib | None of these genes | Phase 2 |
| Eftilagimod Alfa | None of these genes | Phase 2 |
| Eganelisib | None of these genes | Phase 2 |
| Emd-1201081 | None of these genes | Phase 2 |
| Enlonstobart | None of these genes | Phase 2 |
| Envafolimab | None of these genes | Phase 2 |
| Eribulin | None of these genes | Phase 2 |
| Etimupepimut | None of these genes | Phase 2 |
| Etoposide | None of these genes | Phase 2 |
| Evalstotug | None of these genes | Phase 2 |
| Everolimus | None of these genes | Phase 2 |
| Evorpacept | None of these genes | Phase 2 |
| Exlinkibart | None of these genes | Phase 2 |
| Fenretinide | None of these genes | Phase 2 |
| Ferric Carboxymaltose | None of these genes | Phase 2 |
| Ferric Oxyhydroxide | None of these genes | Phase 2 |
| Ferrous Sulfate | None of these genes | Phase 2 |
| Fianlimab | None of these genes | Phase 2 |
| Flutamide | None of these genes | Phase 2 |
| Foretinib | None of these genes | Phase 2 |
| Futuximab | None of these genes | Phase 2 |
| Gilvetmab | None of these genes | Phase 2 |
| Hafnium Oxide | None of these genes | Phase 2 |
| Hydroxyurea | None of these genes | Phase 2 |
| Ibrutinib | None of these genes | Phase 2 |
| Imsapepimut | None of these genes | Phase 2 |
| Infigratinib | None of these genes | Phase 2 |
| Irinotecan | None of these genes | Phase 2 |
| Iron Isomaltoside 1000 | None of these genes | Phase 2 |
| Isosorbide | None of these genes | Phase 2 |
| Ispinesib | None of these genes | Phase 2 |
| Izalontamab | None of these genes | Phase 2 |
| Ladiratuzumab Vedotin | None of these genes | Phase 2 |
| Lapachone | None of these genes | Phase 2 |
| Lenalidomide | None of these genes | Phase 2 |
| Leucovorin | None of these genes | Phase 2 |
| Lifileucel | None of these genes | Phase 2 |
| Linsitinib | None of these genes | Phase 2 |
| Lirilumab | None of these genes | Phase 2 |
| Litronesib | None of these genes | Phase 2 |
| Lobaplatin | None of these genes | Phase 2 |
| Lonafarnib | None of these genes | Phase 2 |
| Lurtotecan | None of these genes | Phase 2 |
| Magrolimab | None of these genes | Phase 2 |
| Metformin | None of these genes | Phase 2 |
| Mirabegron | None of these genes | Phase 2 |
| Mitomycin | None of these genes | Phase 2 |
| Motolimod | None of these genes | Phase 2 |
| Nelistotug | None of these genes | Phase 2 |
| Nintedanib | None of these genes | Phase 2 |
| Niraparib | None of these genes | Phase 2 |
| Nogapendekin Alfa | None of these genes | Phase 2 |
| Olaparib | None of these genes | Phase 2 |
| Oleclumab | None of these genes | Phase 2 |
| Osi-7904 | None of these genes | Phase 2 |
| Oxaliplatin | None of these genes | Phase 2 |
| Ozuriftamab Vedotin | None of these genes | Phase 2 |
| P-276-00 | None of these genes | Phase 2 |
| Patritumab | None of these genes | Phase 2 |
| Patritumab Deruxtecan | None of these genes | Phase 2 |
| Pazopanib | None of these genes | Phase 2 |
| Pegenzileukin | None of these genes | Phase 2 |
| Peginterferon Alfa-2b | None of these genes | Phase 2 |
| Pemetrexed | None of these genes | Phase 2 |
| Penpulimab | None of these genes | Phase 2 |
| Pertuzumab | None of these genes | Phase 2 |
| Pimurutamab | None of these genes | Phase 2 |
| Pirfenidone | None of these genes | Phase 2 |
| Platinum | None of these genes | Phase 2 |
| Plerixafor | None of these genes | Phase 2 |
| Porfimer Sodium | None of these genes | Phase 2 |
| Poziotinib | None of these genes | Phase 2 |
| Prexasertib | None of these genes | Phase 2 |
| Pucotenlimab | None of these genes | Phase 2 |
| Quercetin | None of these genes | Phase 2 |
| Ragifilimab | None of these genes | Phase 2 |
| Ramucirumab | None of these genes | Phase 2 |
| Relatlimab | None of these genes | Phase 2 |
| Remzistotug | None of these genes | Phase 2 |
| Retlirafusp Alfa | None of these genes | Phase 2 |
| Rigosertib | None of these genes | Phase 2 |
| Rilvegostomig | None of these genes | Phase 2 |
| Rivoceranib | None of these genes | Phase 2 |
| Romidepsin | None of these genes | Phase 2 |
| Rosiglitazone | None of these genes | Phase 2 |
| Ruxolitinib | None of these genes | Phase 2 |
| S1? | None of these genes | Phase 2 |
| Sacituzumab Govitecan | None of these genes | Phase 2 |
| Sacituzumab Tirumotecan | None of these genes | Phase 2 |
| Saracatinib | None of these genes | Phase 2 |
| Selinexor | None of these genes | Phase 2 |
| Selvigaltin | None of these genes | Phase 2 |
| Semaxanib | None of these genes | Phase 2 |
| Serplulimab | None of these genes | Phase 2 |
| Setanaxib | None of these genes | Phase 2 |
| Sf-1126 | None of these genes | Phase 2 |
| Sintilimab | None of these genes | Phase 2 |
| Sorafenib | None of these genes | Phase 2 |
| Sulfamethoxazole | None of these genes | Phase 2 |
| Sulindac | None of these genes | Phase 2 |
| Sunitinib | None of these genes | Phase 2 |
| Suratadenoturev | None of these genes | Phase 2 |
| Surufatinib | None of these genes | Phase 2 |
| Surzebiclimab | None of these genes | Phase 2 |
| Tadalafil | None of these genes | Phase 2 |
| Tarloxotinib | None of these genes | Phase 2 |
| Tavokinogene Telseplasmid | None of these genes | Phase 2 |
| Temoporfin | None of these genes | Phase 2 |
| Temsirolimus | None of these genes | Phase 2 |
| Thalidomide | None of these genes | Phase 2 |
| Tipifarnib | None of these genes | Phase 2 |
| Tiragolumab | None of these genes | Phase 2 |
| Tirapazamine | None of these genes | Phase 2 |
| Tisotumab Vedotin | None of these genes | Phase 2 |
| Tk-112690 | None of these genes | Phase 2 |
| Tocilizumab | None of these genes | Phase 2 |
| Tomuzotuximab | None of these genes | Phase 2 |
| Tuparstobart | None of these genes | Phase 2 |
| Ulevostinag | None of these genes | Phase 2 |
| Uliledlimab | None of these genes | Phase 2 |
| Valproic Acid | None of these genes | Phase 2 |
| Vandetanib | None of these genes | Phase 2 |
| Verzistobart | None of these genes | Phase 2 |
| Vidutolimod | None of these genes | Phase 2 |
| Vorinostat | None of these genes | Phase 2 |
| Wnt-974 | None of these genes | Phase 2 |
| Zimberelimab | None of these genes | Phase 2 |
| Abipapogene Suvaplasmid | None of these genes | Phase 1/2 |
| Alisertib | None of these genes | Phase 1/2 |
| Allantoin | None of these genes | Phase 1/2 |
| Amifostine | None of these genes | Phase 1/2 |
| Balstilimab | None of these genes | Phase 1/2 |
| Birinapant | None of these genes | Phase 1/2 |
| Bizalimogene Ralaplasmid | None of these genes | Phase 1/2 |
| Bms-777607 | None of these genes | Phase 1/2 |
| C-188-9 | None of these genes | Phase 1/2 |
| Cilengitide | None of these genes | Phase 1/2 |
| Cintirorgon | None of these genes | Phase 1/2 |
| Com-701 | None of these genes | Phase 1/2 |
| Copanlisib | None of these genes | Phase 1/2 |
| Dazostinag | None of these genes | Phase 1/2 |
| Digoxin | None of these genes | Phase 1/2 |
| Eclutatug | None of these genes | Phase 1/2 |
| Elgemtumab | None of these genes | Phase 1/2 |
| Enzalutamide | None of these genes | Phase 1/2 |
| Etigilimab | None of these genes | Phase 1/2 |
| Evofosfamide | None of these genes | Phase 1/2 |
| Fludarabine | None of these genes | Phase 1/2 |
| Fludarabine Phosphate | None of these genes | Phase 1/2 |
| Fulvestrant | None of these genes | Phase 1/2 |
| Guretolimod | None of these genes | Phase 1/2 |
| Hiltonol | None of these genes | Phase 1/2 |
| Ifinatamab Deruxtecan | None of these genes | Phase 1/2 |
| Inbakicept | None of these genes | Phase 1/2 |
| Interleukin-12 Human Recombinant | None of these genes | Phase 1/2 |
| Ipatasertib | None of these genes | Phase 1/2 |
| Isatuximab | None of these genes | Phase 1/2 |
| Ivuxolimab | None of these genes | Phase 1/2 |
| Ixabepilone | None of these genes | Phase 1/2 |
| Jab-3068 | None of these genes | Phase 1/2 |
| Lemzoparlimab | None of these genes | Phase 1/2 |
| Lutetium Lu177 Edotreotide | None of these genes | Phase 1/2 |
| Lutetium Lu 177 Zadavotide Guraxetan | None of these genes | Phase 1/2 |
| Lutetium Oxodotreotide | None of these genes | Phase 1/2 |
| Morphine | None of these genes | Phase 1/2 |
| Negalstobart | None of these genes | Phase 1/2 |
| Nelitolimod | None of these genes | Phase 1/2 |
| Neo-201 | None of these genes | Phase 1/2 |
| Nt-219 | None of these genes | Phase 1/2 |
| Omega-3-Acid Ethyl Esters | None of these genes | Phase 1/2 |
| Onc-392 | None of these genes | Phase 1/2 |
| Osimertinib | None of these genes | Phase 1/2 |
| Paclitaxel Poliglumex | None of these genes | Phase 1/2 |
| Pamvatamig | None of these genes | Phase 1/2 |
| Pd-360324 | None of these genes | Phase 1/2 |
| Penicillin G | None of these genes | Phase 1/2 |
| Pepinemab | None of these genes | Phase 1/2 |
| Pexidartinib | None of these genes | Phase 1/2 |
| Pexmetinib | None of these genes | Phase 1/2 |
| Renvistobart | None of these genes | Phase 1/2 |
| Rocakinogene Sifuplasmid | None of these genes | Phase 1/2 |
| Sinecatechins | None of these genes | Phase 1/2 |
| Sirolimus | None of these genes | Phase 1/2 |
| Sonolisib | None of these genes | Phase 1/2 |
| Sra-737 | None of these genes | Phase 1/2 |
| Sx-682 | None of these genes | Phase 1/2 |
| Tak-186 | None of these genes | Phase 1/2 |
| Talazoparib | None of these genes | Phase 1/2 |
| Timdarpacept | None of these genes | Phase 1/2 |
| Trastuzumab | None of these genes | Phase 1/2 |
| Trastuzumab Emtansine | None of these genes | Phase 1/2 |
| Troculeucel | None of these genes | Phase 1/2 |
| Urelumab | None of these genes | Phase 1/2 |
| Utomilumab | None of these genes | Phase 1/2 |
| Valemetostat | None of these genes | Phase 1/2 |
| Varlilumab | None of these genes | Phase 1/2 |
| Veliparib | None of these genes | Phase 1/2 |
| Vevoctadekin | None of these genes | Phase 1/2 |
| Vipivotide Tetraxetan Lutetium | None of these genes | Phase 1/2 |
| Vobramitamab Duocarmazine | None of these genes | Phase 1/2 |
| Zalifrelimab | None of these genes | Phase 1/2 |
| Alextatug | None of these genes | Phase 1 |
| Asp-1948 | None of these genes | Phase 1 |
| Asp-1951 | None of these genes | Phase 1 |
| Aspirin | None of these genes | Phase 1 |
| Astuprotimut-R | None of these genes | Phase 1 |
| Atamparib | None of these genes | Phase 1 |
| Azirkitug | None of these genes | Phase 1 |
| Berzosertib | None of these genes | Phase 1 |
| Bivatuzumab | None of these genes | Phase 1 |
| Budigalimab | None of these genes | Phase 1 |
| Cabiralizumab | None of these genes | Phase 1 |
| Camonsertib | None of these genes | Phase 1 |
| Capmatinib | None of these genes | Phase 1 |
| Carrimycin | None of these genes | Phase 1 |
| Cedazuridine | None of these genes | Phase 1 |
| Cholesterol | None of these genes | Phase 1 |
| Clopidogrel | None of these genes | Phase 1 |
| Cv-8102 | None of these genes | Phase 1 |
| Datopotamab Deruxtecan | None of these genes | Phase 1 |
| Decitabine | None of these genes | Phase 1 |
| Doxorubicin | None of these genes | Phase 1 |
| Dtp-348 | None of these genes | Phase 1 |
| E-7766 | None of these genes | Phase 1 |
| Efineptakin Alfa | None of these genes | Phase 1 |
| Elimusertib | None of these genes | Phase 1 |
| Enadenotucirev | None of these genes | Phase 1 |
| Entolimod | None of these genes | Phase 1 |
| Ezabenlimab | None of these genes | Phase 1 |
| Folinic Acid | None of these genes | Phase 1 |
| Ganetespib | None of these genes | Phase 1 |
| Giloralimab | None of these genes | Phase 1 |
| Hpph | None of these genes | Phase 1 |
| Imgatuzumab | None of these genes | Phase 1 |
| Inavolisib | None of these genes | Phase 1 |
| Interferon Alfa-2b | None of these genes | Phase 1 |
| Irx-2 | None of these genes | Phase 1 |
| Itacitinib | None of these genes | Phase 1 |
| Itraconazole | None of these genes | Phase 1 |
| Losartan | None of these genes | Phase 1 |
| Medi-6469 | None of these genes | Phase 1 |
| Merestinib | None of these genes | Phase 1 |
| Mgd-009 | None of these genes | Phase 1 |
| Migoprotafib | None of these genes | Phase 1 |
| Mivavotinib | None of these genes | Phase 1 |
| Mk-2206 | None of these genes | Phase 1 |
| Motexafin Gadolinium | None of these genes | Phase 1 |
| Nanrilkefusp Alfa | None of these genes | Phase 1 |
| Nedisertib | None of these genes | Phase 1 |
| Ng-641 | None of these genes | Phase 1 |
| Nidanilimab | None of these genes | Phase 1 |
| Nilotinib | None of these genes | Phase 1 |
| Numidargistat | None of these genes | Phase 1 |
| Obinutuzumab | None of these genes | Phase 1 |
| Onalespib | None of these genes | Phase 1 |
| Osunprotafib | None of these genes | Phase 1 |
| Oxygen | None of these genes | Phase 1 |
| Pamiparib | None of these genes | Phase 1 |
| Parsaclisib | None of these genes | Phase 1 |
| Peginterferon Alfa-2a | None of these genes | Phase 1 |
| Perflutren | None of these genes | Phase 1 |
| Pexastimogene Devacirepvec | None of these genes | Phase 1 |
| Pradusinstobart | None of these genes | Phase 1 |
| Revdofilimab | None of these genes | Phase 1 |
| Ribociclib | None of these genes | Phase 1 |
| Risovalisib | None of these genes | Phase 1 |
| Rituximab | None of these genes | Phase 1 |
| Rovalpituzumab Tesirine | None of these genes | Phase 1 |
| Sapropterin | None of these genes | Phase 1 |
| Sasanlimab | None of these genes | Phase 1 |
| Sephb4-Hsa | None of these genes | Phase 1 |
| Simlukafusp Alfa | None of these genes | Phase 1 |
| Sitravatinib | None of these genes | Phase 1 |
| Sodium Iodide | None of these genes | Phase 1 |
| Sonidegib | None of these genes | Phase 1 |
| Spartalizumab | None of these genes | Phase 1 |
| Stapokibart | None of these genes | Phase 1 |
| Tavolimab | None of these genes | Phase 1 |
| Tazemetostat | None of these genes | Phase 1 |
| Telisotuzumab Adizutecan | None of these genes | Phase 1 |
| Tetanus Toxoid | None of these genes | Phase 1 |
| Tilarginine | None of these genes | Phase 1 |
| Tilsotolimod | None of these genes | Phase 1 |
| Tucidinostat | None of these genes | Phase 1 |
| Tyrosine | None of these genes | Phase 1 |
| Uprevstobart | None of these genes | Phase 1 |
| Venetoclax | None of these genes | Phase 1 |
| Imatinib | None of these genes | Early phase 1 |
| Methylene Blue Cation | None of these genes | Early phase 1 |
| Pyrimethamine | None of these genes | Early phase 1 |
| Raltegravir | None of these genes | Early phase 1 |
| Sabestomig | None of these genes | Early phase 1 |
| Bupropion | None of these genes | Unknown |
| Molgramostim | None of these genes | Unknown |
| (+/-)Nicotine | None of these genes | Unknown |
| Nicotine | None of these genes | Unknown |
| Pentoxifylline | None of these genes | Unknown |
| Regramostim | None of these genes | Unknown |
| Sargramostim | None of these genes | Unknown |
| Varenicline | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.